Affiliation:
1. Department of Radiology and Imaging, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal
Abstract
ABSTRACT: Objective: The aim of this study is to conduct a descriptive cross sectional study to observe the relationship of lipid profile with fatty liver, as diagnosed by ultrasonography. Methodology: Study population consisted of 105 persons (50 females & 55 males) who were having non-alcoholic fatty liver disease, as diagnosed by ultrasonography. Serum lipid profile reports of the study population was tabulated and compared with grade I, II & III of ultrasonography-diagnosed fatty liver. Result: Grade I (mild) non-alcoholic fatty liver disease was seen in 84.7 %, grade II (moderate) in 13.3 % and grade III (severe) in 1.9% cases. Mean age of the study population was 48.3 years ranging from 25 years (minimum) to 79 years (maximum). Dyslipidemia was found in more than two thirds of our study population. Total cholesterol, triglyceride and low-density lipoprotein were increased in 67.6%, 65.7% and 67.6% respectively. High-density lipoprotein was decreased in 60.9% cases. Mean value of total cholesterol, triglyceride, low-density lipoprotein and high-density lipoprotein were 233.5 gm/dl, 215.5 gm/dl, 148.7 gm/dl and 32.5 gm/dl respectively. When lipid profiles were compared with fatty liver, significant positive correlation was seen between non-alcoholic fatty liver disease with increased serum cholesterol, increased triglyceride, increased low-density lipoprotein & decreased serum high-density lipoprotein. P value was <0.001 in all the cases. Different grades of non-alcoholic fatty liver disease and individual lipid components showed no significant correlation. Conclusion: This study showed more than two thirds of ultrasonography-diagnosed non-alcoholic fatty liver had abnormal lipid profile. So, safe and non-invasive ultrasonography is very useful for screening and early detection of dyslipidemia in patients.
Publisher
Oriental Scientific Publishing Company
Subject
Drug Discovery,Agronomy and Crop Science,Biotechnology
Reference11 articles.
1. 1. Puri P, Sanyal AJ. Nonalcoholic fatty liver disease: Definitions, risk factors, and workup. Clin Liver Dis (Hoboken). 2012 Sep 25;1(4):99-103.
2. 2. Sen A, Kumar J, Misra RP, Uddin M, Shukla PC. Lipid profile of patients having non-alcoholic fatty liver disease as per ultrasound findings in north Indian population: A retrospective observational study.J Med Allied Sci. 2013; 3 (2): 59-62.
3. 3. Chitturi S, Farrell GC, Hashimoto E. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol. 2007; 22:778.
4. 4. Williams CD, Stengel J, Asike MI. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011; 140:124.
5. 5. Marchesini G, Bugianesi E, Forlani G. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37:917.